Excess prevalence of fasting and postmethionine-loading hyperhomocysteinemia in stable renal transplant recipients

被引:80
作者
Bostom, AG
Gohh, RY
Tsai, MY
HopkinsGarcia, BJ
Nadeau, MR
Bianchi, LA
Jacques, PF
Rosenberg, IH
Selhub, J
机构
[1] TUFTS NEW ENGLAND MED CTR,USDA,JEAN MAYER HUMAN NUTR RES CTR,BOSTON,MA
[2] RHODE ISL HOSP,DIV RENAL DIS & TRANSPLANT SERV,PROVIDENCE,RI
[3] UNIV MINNESOTA HOSP & CLIN,DEPT LAB MED & PATHOL,MINNEAPOLIS,MN 55455
关键词
homocysteine; renal function; folate; vitamin B-6;
D O I
10.1161/01.ATV.17.10.1894
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hyperhomocysteinemia, either fasting or after methionine loading, may contribute to the increased incidence of cardiovascular disease events experienced by renal transplant recipients. Limited data are available on fasting homocysteine (Hcy) levels, and none on postmethionine-loading Hcy levels, in these patients. We assessed the prevalence and potential determinants of fasting and postmethionine-loading hyperhomocysteinemia in 29 stable renal transplant recipients and 58 age- and sex-matched, population-based controls free of renal disease with serum creatinine levels of 1.5 mg/dL or less. Total (t) plasma Hcy was determined fasting and 2 hours after methionine loading, along with fasting determinations of the B-vitamin cofactors/substrates for Hcy metabolism, ie, pyridoxal 5'-phosphate, B-12, and folate and serum creatinine. Geometric mean fasting (18.1 versus 9.8 mu M, P<.001) and postmethionine-loading increase (22.0 versus 15.2, P=.001) in tHcy levels were significantly greater in the renal transplant recipients, as were the prevalence odds (with 95% confidence intervals) for fasting [14.8 (3.4-64.7)], postmethionine loading [6.9 (1.5-32.8)], combined fasting and postmethionine-loading [18.0 (2.3-142.1)] hyperhomocysteinemia, and inadequate circulating folate [4.2 (1.1-16.5)] or pyridoxal 5'-phosphate [3.2 (0.9-11.0) status. Correlation analyses suggested important potential relationships between creatinine and both fasting (+0.64, P<.001) and postmethionine-load increase (+0.38, P=.045) in tHcy, folate and fasting (-0.41, P=.025) tHcy, and pyridoxal 5'-phosphate and postmethionine-loading increase (-0.33, P=.091) in tHcy. We conclude that there is an excess prevalence of fasting and postmethionine-loading hyperhomocysteinemia in stable renal transplant recipients. Renal function is related to both fasting and postmethionine loading-hyperhomocysteinemia, inadequate folate status is associated with fasting hyperhomocysteinemia, and inadequate vitamin B-6 status may be related to postmethionine-loading hyperhomocysteinemia in this patient population.
引用
收藏
页码:1894 / 1900
页数:7
相关论文
共 69 条
  • [1] DETERMINATION OF FREE AND TOTAL HOMOCYSTEINE IN HUMAN-PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH FLUORESCENCE DETECTION
    ARAKI, A
    SAKO, Y
    [J]. JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1987, 422 : 43 - 52
  • [2] The effect of reduced glomerular filtration rate on plasma total homocysteine concentration
    Arnadottir, M
    Hultberg, B
    NilssonEhle, P
    Thysell, H
    [J]. SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1996, 56 (01) : 41 - 46
  • [3] Hyperhomocysteinemia in cyclosporine-treated renal transplant recipients
    Arnadottir, M
    Hultberg, B
    Vladov, V
    NilssonEhle, P
    Thysell, H
    [J]. TRANSPLANTATION, 1996, 61 (03) : 509 - 512
  • [4] SERUM TOTAL HOMOCYSTEINE AND CORONARY HEART-DISEASE
    ARNESEN, E
    REFSUM, H
    BONAA, KH
    UELAND, PM
    FORDE, OH
    NORDREHAUG, JE
    [J]. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1995, 24 (04) : 704 - 709
  • [5] BACHMANN J, 1995, J AM SOC NEPHROL, V6, P121
  • [6] NET UPTAKE OF PLASMA HOMOCYSTEINE BY THE RAT-KIDNEY IN-VIVO
    BOSTOM, A
    BROSNAN, JT
    HALL, B
    NADEAU, MR
    SELHUB, J
    [J]. ATHEROSCLEROSIS, 1995, 116 (01) : 59 - 62
  • [7] BOSTOM AG, 1995, CLIN CHEM, V41, P948
  • [8] Folate status is the major determinant of fasting total plasma homocysteine levels in maintenance dialysis patients
    Bostom, AG
    Shemin, D
    Lapane, KL
    Nadeau, MR
    Sutherland, P
    Chan, J
    Rozen, R
    Yoburn, D
    Jacques, PF
    Selhub, J
    Rosenberg, IH
    [J]. ATHEROSCLEROSIS, 1996, 123 (1-2) : 193 - 202
  • [9] High dose B-vitamin treatment of hyperhomocysteinemia in dialysis patients
    Bostom, AG
    Shemin, D
    Lapane, KL
    Hume, AL
    Yoburn, D
    Nadeau, MR
    Bendich, A
    Selhub, J
    Rosenberg, IH
    [J]. KIDNEY INTERNATIONAL, 1996, 49 (01) : 147 - 152
  • [10] HYPERHOMOCYSTEINEMIA AND TRADITIONAL CARDIOVASCULAR-DISEASE RISK-FACTORS IN END-STAGE RENAL-DISEASE PATIENTS ON DIALYSIS - A CASE-CONTROL STUDY
    BOSTOM, AG
    SHEMIN, D
    LAPANE, KL
    MILLER, JW
    SUTHERLAND, P
    NADEAU, M
    SEYOUM, E
    HARTMAN, W
    PRIOR, R
    WILSON, PWF
    SELHUB, J
    [J]. ATHEROSCLEROSIS, 1995, 114 (01) : 93 - 103